Lv41
514 积分 2024-03-15 加入
From traditional to targeted: the changing trajectory of therapies in dermatomyositis
3天前
已完结
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation
3天前
已完结
Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open-labeled single-blinded randomized controlled trial
3天前
已完结
Reply to ‘Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa’ by Holgersen et al
3天前
已完结
Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis
3天前
已完结
Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis
8天前
已完结
Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa
8天前
已完结
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
8天前
已完结
Topical Therapy for Atopic Dermatitis: What is New and the New Paradigm
8天前
已完结
The Safety and Efficacy of Interleukin-17 Inhibitors for Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
16天前
已关闭
皖公网安备34019202002308
